[HTML][HTML] Bacteriophages as nanocarriers for targeted drug delivery and enhanced therapeutic effects
SC Emencheta, AL Onugwu, CF Kalu, PN Ezinkwo… - Materials …, 2024 - pubs.rsc.org
The effective delivery of therapeutic agents is as important as the active therapeutic agent
because it may make or mar the outcome. Traditional/conventional drug delivery systems …
because it may make or mar the outcome. Traditional/conventional drug delivery systems …
Bioengineered carbohydrate polymers for colon‐specific drug release: Current trends and future prospects
D Bhirud, S Bhattacharya… - Journal of Biomedical …, 2024 - Wiley Online Library
The worldwide health burden of colorectal cancer is still substantial, and traditional
chemotherapeutic drugs sometimes have poor selectivity, which can result in systemic …
chemotherapeutic drugs sometimes have poor selectivity, which can result in systemic …
[HTML][HTML] Nanotechnology-based strategies overcoming the challenges of retinoblastoma: a comprehensive overview and future perspectives
S Hatem, D Mohammed, N Ezzat - Future Journal of Pharmaceutical …, 2024 - Springer
Background Retinoblastoma (RB) is a rare type of pediatric ocular cancer with difficulty in
treatment and detection owing to alterations in tumor suppressor genes and the lack of …
treatment and detection owing to alterations in tumor suppressor genes and the lack of …
Advancements in the diagnosis, prognosis, and treatment of retinoblastoma
Retinoblastoma (RB) is a prevalent primitive intraocular malignancy in children, particularly
in those younger than age 3 years. RB is caused by mutations in the RB1 gene. In …
in those younger than age 3 years. RB is caused by mutations in the RB1 gene. In …